EUVIMEDОткрийте EUVIMED
Übersichtsarbeit

Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways

Bojun Tang iD, Nengqiao Fang iD, Tianru Wang iD, Xianli Meng iD, Jinsong Su iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70266 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2026. Written by Bojun Tang and 4 co-authors. Institution: State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Si…. Major MEDLINE topics: Antirheumatic Agents, Arthritis, Rheumatoid, Drugs, Chinese Herbal, Medicine, Chinese Traditional. Cited 1 times so far (Crossref); 202 references. Funded by: The National Natural Science Foundation of China, Sichuan Provincial Key Research and Development Program, National Key Research and Development Program of China.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic synovitis and multi‐joint destruction. The disease course is prolonged, recurrent, and associated with high disability rates. Patients often experience significant physical and mental suffering due to persistent pain, joint deformities, and multisystem complications. Clinical treatment faces dual challenges of controlling inflammation and delaying structural damage. Although current mainstream chemical drugs, such as disease‐modifying antirheumatic drugs (DMARDs), can relieve symptoms, their long‐term use can easily cause adverse reactions, including lung involvement and cardiovascular disease. Although biological agents exhibit strong targeting capabilities, they are costly and immunosuppressive, thus increasing the risk of infection and other complications. These limitations highlight the urgent need for developing new therapeutic agents with improved safety and efficacy profiles. In this context, traditional Chinese ethnomedicines, rooted in the medical systems of China's ethnic minorities, have gradually attracted attention due to their potential for multicomponent synergy, favorable safety profiles, and low cost. They have thus become a research hotspot for complementary and alternative RA therapies in recent years. A comprehensive literature review reveals that existing anti‐RA studies of traditional Chinese ethnomedicines mainly focus on regulating inflammation‐related signaling pathways. However, issues such as fragmented target verification and unclear active ingredients remain. Therefore, this study comprehensively reviews the research progress on the molecular mechanisms by which traditional Chinese ethnomedicines regulate RA‐related signaling pathways. It also examines the regulatory effects of certain ethnomedicines on crosstalk among multiple pathways and identifies active components in selected ethnomedicines. Acknowledging that the current evidence base is predominantly preclinical, this review highlights the critical need for rigorous clinical trials and comprehensive safety assessments to validate these findings. Ultimately, this work aims to provide new insights into clarifying the mechanisms of action of traditional Chinese ethnomedicines and to guide future targeted research for developing potential anti‐RA drugs.

Subjects

MeSH terms (MEDLINE)

Antirheumatic AgentsArthritis, RheumatoidDrugs, Chinese HerbalMedicine, Chinese TraditionalSignal TransductionAnimalsHumans

Author keywords

crosstalkmechanism of actionrheumatoid arthritissignaling pathwaystraditional Chinese ethnomedicines

Substances

Antirheumatic AgentsDrugs, Chinese Herbal

Authors and institutions

  • State Key Laboratory of Southwestern Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.
  • Institute of High Altitude Multimorbidity/TCM-Integrated High Altitude Medicine Center, Hospital of Chengdu University of TCM, Chengdu, Sichuan, People's Republic of China.
  • State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.

ORCID profiles: Bojun Tang, Nengqiao Fang, Tianru Wang, Xianli Meng, Jinsong Su

Funding

  • The National Natural Science Foundation of China
  • Sichuan Provincial Key Research and Development Program
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Cite

APA

Tang, B., Fang, N., Wang, T., Meng, X., & Su, J. (2026). Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways. Phytotherapy Research. https://doi.org/10.1002/ptr.70266

Vancouver

Tang B, Fang N, Wang T, Meng X, Su J. Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways. Phytotherapy Research. 2026. doi:10.1002/ptr.70266

BibTeX
@article{Tang2026,
  author = {Tang, Bojun and Fang, Nengqiao and Wang, Tianru and Meng, Xianli and Su, Jinsong},
  title = {Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70266}
}
Start for free →